ShareCafe Small Cap Hidden Gems Presentation
Jon Pilcher - Managing Director & CEO - Neuren Pharmaceuticals Limited (ASX:NEU) is developing new therapies for highly debilitating neurodevelopmental disorders that emerge in early childhood.
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Neuren Pharmaceuticals Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Neuren Pharmaceuticals Limited a question about this update.